中性粒细胞胞外陷阱
细胞外
医学
坏死
肾
急性肾损伤
病理
急性肾小管坏死
炎症
免疫学
生物
细胞生物学
内科学
内分泌学
作者
Daigo Nakazawa,Santhosh V. Kumar,Julian A. Marschner,Jyaysi Desai,Alexander Holderied,Lukas Rath,Franziska Kraft,Yutian Lei,Yuichiro Fukasawa,Gilbert Moeckel,Maria Lucia Angelotti,Helen Liapis,Hans‐Joachim Anders
出处
期刊:Journal of The American Society of Nephrology
日期:2017-01-10
卷期号:28 (6): 1753-1768
被引量:279
标识
DOI:10.1681/asn.2016080925
摘要
Severe AKI is often associated with multiorgan dysfunction, but the mechanisms of this remote tissue injury are unknown. We hypothesized that renal necroinflammation releases cytotoxic molecules that may cause remote organ damage. In hypoxia-induced tubular epithelial cell necrosis in vitro, histone secretion from ischemic tubular cells primed neutrophils to form neutrophil extracellular traps. These traps induced tubular epithelial cell death and stimulated neutrophil extracellular trap formation in fresh neutrophils. In vivo, ischemia-reperfusion injury in the mouse kidney induced tubular necrosis, which preceded the expansion of localized and circulating neutrophil extracellular traps and the increased expression of inflammatory and injury-related genes. Pretreatment with inhibitors of neutrophil extracellular trap formation reduced kidney injury. Dual inhibition of neutrophil trap formation and tubular cell necrosis had an additive protective effect. Moreover, pretreatment with antihistone IgG suppressed ischemia-induced neutrophil extracellular trap formation and renal injury. Renal ischemic injury also increased the levels of circulating histones, and we detected neutrophil infiltration and TUNEL-positive cells in the lungs, liver, brain, and heart along with neutrophil extracellular trap accumulation in the lungs. Inhibition of neutrophil extracellular trap formation or of circulating histones reduced these effects as well. These data suggest that tubular necrosis and neutrophil extracellular trap formation accelerate kidney damage and remote organ dysfunction through cytokine and histone release and identify novel molecular targets to limit renal necroinflammation and multiorgan failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI